Biblio
When is the best time and grade to start ruxolitinib in corticosteroid-refractory acute graft-versus-host-disease: A multi-center research. Clin Transplant. 2023:e15195.
Validation of the imatinib-therapy failure model. Leukemia. 2023.
Physicians' knowledge of invasive fungal disease in China. Mycoses. 2023.
Myelodysplasia-related gene mutations are associated with favorable prognosis in patients with TP53-mutant acute myeloid leukemia. Ann Hematol. 2024.
. Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study. Clin Lymphoma Myeloma Leuk. 2024.
Clinical characteristics, genetic alterations, and prognosis of adult T-cell leukemia/lymphoma: an 11-year multicenter retrospective study in China. Am J Cancer Res. 2024;14(4):1649-1661.
Can Published Population Pharmacokinetic Models of Busulfan be used for Individualized Dosing in Chinese pediatric patients undergoing Hematopoietic Stem Cell Transplantation: An External Evaluation. J Clin Pharmacol. 2021.
.